Therapeutic Workshop
Non-Cancer Immunotherapy: "It's not just about cancer anymore"
Wednesday, February 13, 2008
9:30 AM
Basildon Room
When we think of immunotherapeutics, we tend to associate them as anti-cancer candidates. However, their utility is much more far-reaching than just oncology. Recent clinical setbacks for cancer immunotherapies may increase visibility and attention on how we can effectively harness and train the immune system to recognize and attack threats such as HIV, HCV, neurodegenerative disorders, asthma and allergies, and even addiction. Panelists will discuss their fascinating use of their unique immunotherapy technologies for indications that you may not expect.
Moderators
- Rahul Jasujua, Ph.D.; Managing Director, Life Sciences, MDB Capital
Panelists
- Eldon R. Smith, MD; Sr. Vice President and CMO, Vasogen
- Charles A. Nicolette, Ph.D.; CSO, Research and Development, Argos Therapeutics
- Sudhir Agrawal, D. Phil.; CEO, CSO, Idera Pharmaceuticals
- Richard Furie, MD; Chief of Rheumatology & Allergy and Clinical Immunology, The North Shore Long Island Jewish Health System
Who's Who
Expert: Richard Furie, MD, is Chief of Rheumatology & Allergy and Clinical Immunology at the North Shore Long Island Jewish Health System in New York. He also serves as Director of the Program in Novel Therapeutics and the Musculoskeletal Clinical Research Program. Dr. Furie's interests include patient care, education, and clinical investigation in the area of drug development for rheumatic diseases.